Involvement of high mobility group box‐1 in imiquimod‐induced psoriasis‐like mice model

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of dermatology (Print)

• Publication date

  2017-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/1346-8138.13695PMID 27943400
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased serum HMGB1 levels in patients with Henoch–Schönlein purpura

  2014cited by this paper
• Interplay between CXCR2 and BLT1 Facilitates Neutrophil Infiltration and Resultant Keratinocyte Activation in a Murine Model of Imiquimod-Induced Psoriasis

  2014cited by this paper
• Elevated serum levels of high mobility group box protein 1 (HMGB1) in patients with ankylosing spondylitis and its association with disease activity and quality of life

  2013cited by this paper
• Increased HMGB1 serum levels and altered HMGB1 expression in patients with psoriasis vulgaris

  2013cited by this paper
• Paeoniflorin suppresses vascular damage and the expression of E‐selectin and ICAM‐1 in a mouse model of cutaneous Arthus reaction

  2013cited by this paper
• IL-27 activates Th1-mediated responses in imiquimod-induced psoriasis-like skin lesions.

  2013cited by this paper
• Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 "alarmins" psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis.

  2012cited by this paper
• Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion.

  2012cited by this paper
• Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis

  2011cited by this paper
• Enhanced HMGB1 Expression May Contribute to Th17 Cells Activation in Rheumatoid Arthritis

  2011cited by this paper
• Glycyrrhizin attenuates rat ischemic spinal cord injury by suppressing inflammatory cytokines and HMGB1

  2011cited by this paper
• HMGB1 in systemic lupus Erythematosus: Its role in cutaneous lesions development.

  2010cited by this paper
• Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis1

  2009cited by this paper
• Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells.

  2008cited by this paper
• Cholinergic Anti-Inflammatory Pathway Activity and High Mobility Group Box-1 (HMGB1) Serum Levels in Patients with Rheumatoid Arthritis

  2007cited by this paper
• Pathogenesis and therapy of psoriasis

  2007cited by this paper
• Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities.

  2007cited by this paper
• Misbehaving macrophages in the pathogenesis of psoriasis.

  2006cited by this paper
• A placebo‐controlled randomized study on the clinical effectiveness, immunohistochemical changes and protoporphyrin IX accumulation in fractionated 5‐aminolaevulinic acid‐photodynamic therapy in patients with psoriasis

  2006cited by this paper
• Observations of psoriasis in the absence of therapeutic intervention identifies two unappreciated morphologic variants, thin-plaque and thick-plaque psoriasis, and their associated phenotypes.

  2006cited by this paper
• High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

  2005cited by this paper
• Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells.

  2003cited by this paper
• IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism.

  2003cited by this paper
• IFN-γ Induces High Mobility Group Box 1 Protein Release Partly Through a TNF-Dependent Mechanism1

  2003cited by this paper
• Activation of gene expression in human neutrophils by high mobility group box 1 protein.

  2003cited by this paper
• High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes

  2000cited by this paper

• NMI promotes the secretion of IL-17 and exacerbates psoriasis.

  2026cites this paper
• Topical adhesive spatio-temporal nanosystem co-delivering chlorin e6 and HMGB1 inhibitor glycyrrhizic acid for in situ psoriasis chemo-phototherapy

  2025cites this paper
• HMGB1: new biomarker and therapeutic target of autoimmune and autoinflammatory skin diseases

  2025cites this paper
• Intradermal delivery of teriflunomide loaded emulsomes using hollow microneedles for effective minimally invasive psoriasis management.

  2025cites this paper
• HMGB1 regulates Th17 cell differentiation and function in patients with psoriasis

  2024cites this paper
• Green preparation and evaluation of the anti‐psoriatic activity of vesicular elastic nanocarriers of kojic acid from Aspergillus oryzae N12: Repurposing of a dermo‐cosmetic lead

  2024cites this paper
• Combined photodynamic therapy and hollow microneedle approach for effective non-invasive delivery of hypericin for the management of imiquimod-induced psoriasis

  2024cites this paper
• Damage-Associated Molecular Patterns, a Class of Potential Psoriasis Drug Targets

  2024cites this paper
• Resistin – A Plausible Therapeutic Target in the Pathogenesis of Psoriasis

  2023influential citation
• Keratinocyte derived HMGB1 aggravates psoriasis dermatitis via facilitating inflammatory polarization of macrophages and hyperproliferation of keratinocyte.

  2023cites this paper
• Could serum HMGB1 levels be a predictor associated with psoriatic arthritis?

  2023cites this paper
• The role of HMGB1 in inflammatory skin diseases.

  2022cites this paper
• Nanaomycin E inhibits NLRP3 inflammasome activation by preventing mitochondrial dysfunction.

  2022cites this paper
• The Immune Tolerance Role of the HMGB1-RAGE Axis

  2021cites this paper
• HMGB-1 in Psoriasis

  2021influential citation
• Peritumoral B cells drive proangiogenic responses in HMGB1-enriched esophageal squamous cell carcinoma

  2021cites this paper
• Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation

  2020cites this paper
• The Anti-inflammatory Effects of HMGB1 Blockades in a Mouse Model of Cutaneous Vasculitis

  2020cites this paper
• Advanced Characterization of Imiquimod-Induced Psoriasis-Like Mouse Model

  2020cites this paper
• Ghrelin attenuates imiquimod‐induced psoriasiform skin inflammation in mice

  2019cites this paper